1. Signaling Pathways
  2. Anti-infection
  3. Bacterial

Bacterial

Anything that destroys bacteria or suppresses their growth or their ability to reproduce. Heat, chemicals such as chlorine, and antibiotic drugs all have antibacterial properties. Many antibacterial products for cleaning and handwashing are sold today. Such products do not reduce the risk for symptoms of viral infectious diseases in otherwise healthy persons. This does not preclude the potential contribution of antibacterial products to reducing symptoms of bacterial diseases in the home.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-B1295R
    Lithium citrate tetrahydrate (Standard)
    Inhibitor
    Lithium citrate (tetrahydrate) (Standard) is the analytical standard of Lithium citrate (tetrahydrate). This product is intended for research and analytical applications. Lithium citrate (Litarex) tetrahydrate is a natural preservative and food tartness enhancer. Lithium citrate tetrahydrate induces apoptosis and cell cycle arrest at G2/M phase and S phase in HaCaT cells. Lithium citrate tetrahydrate cause oxidative damage of the liver by means of the decrease of antioxidative enzyme activities. Lithium citrate tetrahydrate is also an acidulant, emulsifier, sequestrant and buffering agent widely used across many industries.
    Lithium citrate tetrahydrate (Standard)
  • HY-N5192
    Galacardin A
    Inhibitor
    Galacardin A has anti-Gram-positive bacterial activity.
    Galacardin A
  • HY-139987A
    LeuRS-IN-1 hydrochloride
    Inhibitor
    LeuRS-IN-1 hydrochloride is a potent, orally active M. tuberculosis leucyl-tRNA synthetase (M.tb LeuRS) inhibitor. LeuRS-IN-1 hydrochloride has IC50 and Kd values of 0.06 μM, 0.075 μM for M.tb LeuRS, respectively. LeuRS-IN-1 hydrochloride inhibits human cytoplasmic LeuRS (IC50=38.8 μM), and HepG2 protein synthesis (EC50=19.6 μM).
    LeuRS-IN-1 hydrochloride
  • HY-A0059R
    Nifuratel (Standard)
    Inhibitor
    Nifuratel (Standard) is the analytical standard of Nifuratel. This product is intended for research and analytical applications. Nifuratel (NF 113, SAP 113) is a broad-spectrum antibiotic with activity against bacteria, fungi and trichomonas.
    Nifuratel (Standard)
  • HY-181760
    Quorum sensing-IN-11
    Inhibitor
    Quorum sensing-IN-11 is a quorum sensining inhibitor and a LasR antagonist with an IC50 of 0.7399 μM. Quorum sensing-IN-11 inhibits biofilm, pyocyanin formation and swimming motility in Pseudomonas aeruginosa. Quorum sensing-IN-11 can be used for the research of Pseudomonas aeruginosa infection.
    Quorum sensing-IN-11
  • HY-156416
    LtaS-IN-2
    Inhibitor
    LtaS-IN-2 (compound 13) is a inhibitor of LTA synthesis, and shows antibacterial activity against S. aureus and S. epidermidis, with the MIC90 of 0.5 μg/mL and 1 μg/mL, respectively. LtaS-IN-2 is a derivative of LtaS-IN-1 (HY-135813).
    LtaS-IN-2
  • HY-N15119
    Polymyxin S1
    Inhibitor
    Polymyxin S1 is found in Bacillus Polymyxa RS-6 and is resistant to Gram-positive bacteria.
    Polymyxin S1
  • HY-N14607
    Pacidamycin 5
    Inhibitor
    Pacidamycin 5 has inhibitory effect on Pseudomonas aeruginosa. Pacidamycin 5 also has effect on a few strains of bacteria such as Suppurative staphylococcus and Escherichia coli.
    Pacidamycin 5
  • HY-158700
    DprE1-IN-10
    Inhibitor
    DprE1-IN-10 (hit 2) is a Decaprenylphosphoryl-β-D-ribose-2′-epimerase (DprE1) inhibitor. DprE1-IN-10 can be used for tuberculosis research.
    DprE1-IN-10
  • HY-N14005
    Cephamycin A
    Inhibitor
    Cephalomycin A shows weak activity against Gram-positive and negative bacteria.
    Cephamycin A
  • HY-N14293
    4-Methylaeruginoic acid
    Inhibitor
    4-Methylaeruginoic acid is an antibiotic and is cytotoxic to several human tumor cell lines.
    4-Methylaeruginoic acid
  • HY-167669
    Tioxacin
    Inhibitor
    Tioxacin is an orally active bactericide agent. Tioxacin combined with aliphatic amines has activities against G(+) and G (-) bacteria, including Escherichia coli resistant to Nalidixic acid (HY-B0398) and Pseudomonas aeruginosa.
    Tioxacin
  • HY-129331
    Neothramycin A
    Inhibitor
    Neothramycin A is an antibiotic, which can be isolated from Streptomyces. Neothramycin A exhibits board spectrum antimicrobial activity, inhibits Staphylococcus aureus, Klebsiella pneumoniae, Escherichia coli W677, and Saccharomyces cerevisia with MIC of 25-50 μg/mL. Neothramycin A exhibits antitumor efficacy against leukemia in mouse models.
    Neothramycin A
  • HY-N14392
    Fluoropolyoxin M
    Inhibitor
    Fluoropolyoxin M has the inhibitory activity of Escherichia coli and Streptococcus faecalis.
    Fluoropolyoxin M
  • HY-19647
    Ritipenem acoxil
    Inhibitor
    Ritipenem acoxil (FCE 22891; RIPM-AC) is an oral active beta-lactamase antibiotic and can be used for study of bacterial pneumonia.
    Ritipenem acoxil
  • HY-174227
    Topoisomerase inhibitor 6
    Inhibitor
    Topoisomerase inhibitor 6 (Compound REDX05931) is a dual irreversible inhibitor of DNA gyrase and topoisomerase IV (MIC=0.06 μg/mL against fluoroquinolone-resistant S. aureus). Topoisomerase inhibitor 6 blocks DNA strand break-reunion, inducing lethal DNA damage. Topoisomerase inhibitor 6 is promising for research of Gram-positive bacterial infections (e.g., S. aureus, S. pneumoniae).
    Topoisomerase inhibitor 6
  • HY-121136A
    Chartreusin sodium
    Chartreusin sodium is an antibiotic that is active against certain Gram-positive organisms and mycobacteria. Chartreusin is also active against the Micrococcus fiyogenes v. aureus phage.
    Chartreusin sodium
  • HY-N14157
    Epelmycin C
    Inhibitor
    Epelmycin C has anti-Gram positive, negative bacteria and candida albicans activity, and has anti-leukemic L1210 activity, which is stronger than Aclacinomycin.
    Epelmycin C
  • HY-N14673
    Helvecardin A
    Inhibitor
    Helvecardin A is a glycopeptidtic antibiotic. Helvecardin A has strong activity of anti-aerobic and anaerobic Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus.
    Helvecardin A
  • HY-B0322B
    Sulfamethoxazole 1000 µg/mL in methanol
    Inhibitor 99%
    Sulfamethoxazole (Ro 4-2130) 1000 μg/mL in methanol is a sulfonamide antibiotic with a widespread antibacterial activity. Sulfamethoxazole 1000 μg/mL in methanol inhibits bacterial folate metabolism by competing with 4-Aminobenzoic acid (HY-B1008) (PABA) to act on dihydropteroate synthetase and dihydropteroate reductase. Sulfamethoxazole 1000 μg/mL in methanol can be used for the study of urinary tract infections (UTIs), prostatitis, and bronchitis.
    Sulfamethoxazole 1000 µg/mL in methanol
Cat. No. Product Name / Synonyms Application Reactivity